enVVeno Medical Corporation
Price Action
Technical Summary
DOWNTRENDenVVeno Medical Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 99), indicating clear outperformance against the broad market. Earnings growth of 98% provides fundamental context to the price action. Investors should exercise caution due to high volatility (121% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $11.39 | -12.75% | BELOW |
| 50 SMA | $11.13 | -10.68% | BELOW |
| 100 SMA | $11.15 | -10.85% | BELOW |
| 150 SMA | $14.46 | -31.24% | BELOW |
| 200 SMA | $31.85 | -68.79% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NVNO in an uptrend right now?
NVNO has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is NVNO overbought or oversold?
NVNO's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is NVNO outperforming the market?
NVNO has a Relative Strength (RS) Rating of 99 out of 99. Yes, NVNO is a market leader, outperforming 99% of all stocks over the past 12 months.
Where is NVNO in its 52-week range?
NVNO is trading at $9.94, which is 76% of its 52-week high ($13.00) and 76% above its 52-week low ($0.30).
How volatile is NVNO?
NVNO has a Beta of 2.02 and 52-week volatility of 121%. It's more volatile than the S&P 500 - expect bigger swings.